Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Colman

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Current Treatment Options in Oncology|June 24, 2016
Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and FutureRicky Chen, Adam L Cohen, Howard Colman
Neurosurgical Focus|June 2, 2018
Introduction. Update on adult neuro-oncologyHoward Colman, Manfred Westphal, John H Sampson
Current Neurology and Neuroscience Reports|March 28, 2013
IDH1 and IDH2 mutations in gliomasAdam L Cohen, Sheri L Holmen, Howard Colman
Journal of Neurosurgery|December 10, 2016
Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case reportAmol Raheja, Howard Colman, Cheryl A Palmer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 11, 2017
Glioma Subclassifications and Their Clinical SignificanceRicky Chen, Matthew Smith-Cohn, Adam L Cohen, et al.
CNS Oncology|December 11, 2019
Challenges of targeting <i>BRAF</i> V600E mutations in adult primary brain tumor patients: a report of two casesMatthew Smith-Cohn, Christian Davidson, Howard Colman, et al.
Journal of Neuro-Oncology|February 17, 2017
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trialMarc C Chamberlain, Howard Colman, Bryan T Kim, et al.
Case Reports in Oncology|September 11, 2013
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First ReportAdam L Cohen, Karen Salzman, Cheryl Palmer, et al.
World Neurosurgery|January 3, 2016
The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells RegulationMichael Karsy, Jian Guan, Randy Jensen, et al.
Neurosurgery Clinics of North America|March 26, 2016
Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising HorizonsMichael Karsy, Jian Guan, Adam Cohen, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Current Treatment Options in Oncology|June 24, 2016
Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and FutureRicky Chen, Adam L Cohen, Howard Colman
Neurosurgical Focus|June 2, 2018
Introduction. Update on adult neuro-oncologyHoward Colman, Manfred Westphal, John H Sampson
Current Neurology and Neuroscience Reports|March 28, 2013
IDH1 and IDH2 mutations in gliomasAdam L Cohen, Sheri L Holmen, Howard Colman
Journal of Neurosurgery|December 10, 2016
Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case reportAmol Raheja, Howard Colman, Cheryl A Palmer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 11, 2017
Glioma Subclassifications and Their Clinical SignificanceRicky Chen, Matthew Smith-Cohn, Adam L Cohen, et al.
CNS Oncology|December 11, 2019
Challenges of targeting <i>BRAF</i> V600E mutations in adult primary brain tumor patients: a report of two casesMatthew Smith-Cohn, Christian Davidson, Howard Colman, et al.
Journal of Neuro-Oncology|February 17, 2017
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trialMarc C Chamberlain, Howard Colman, Bryan T Kim, et al.
Case Reports in Oncology|September 11, 2013
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First ReportAdam L Cohen, Karen Salzman, Cheryl Palmer, et al.
World Neurosurgery|January 3, 2016
The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells RegulationMichael Karsy, Jian Guan, Randy Jensen, et al.
Neurosurgery Clinics of North America|March 26, 2016
Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising HorizonsMichael Karsy, Jian Guan, Adam Cohen, et al.
Pageof 16